Jane Street
CRL icon

Jane Street’s Charles River Laboratories CRL Stock Holding History

Jane Street’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.87M Buy
34,700
+21,900
+171% +$3.9M ﹤0.01% 3118
2026
Q1 		$2.21M Buy
12,800
+4,900
+62% +$909K ﹤0.01% 4893
2025
Q4 		$1.58M Sell
7,900
-14,000
-64% -$2.54M ﹤0.01% 5255
2025
Q3 		$3.43M Buy
21,900
+17,400
+387% +$2.76M ﹤0.01% 4008
2025
Q2 		$683K Buy
4,500
+3,000
+200% +$400K ﹤0.01% 6352
2025
Q1 		$226K Sell
1,500
-19,500
-93% -$3.27M ﹤0.01% 8272
2024
Q4 		$3.88M Sell
21,000
-12,200
-37% -$2.35M ﹤0.01% 3033
2024
Q3 		$6.54M Buy
+33,200
New +$6.9M ﹤0.01% 2437
2023
Q2 		– Sell
-96,600
Closed -$19.5M – 8787
2023
Q1 		$19.5M Buy
+96,600
New +$21.9M 0.01% 1028
2022
Q4 		– Sell
-1,100
Closed -$216K – 9268
2022
Q3 		$216K Sell
1,100
-800
-42% -$173K ﹤0.01% 8047
2022
Q2 		$407K Buy
+1,900
New +$464K ﹤0.01% 7098
2022
Q1 		– Sell
-67,600
Closed -$25.5M – 10374
2021
Q4 		$25.5M Sell
67,600
-7,000
-9% -$2.72M 0.01% 1012
2021
Q3 		$30.8M Buy
74,600
+7,600
+11% +$3.16M 0.01% 836
2021
Q2 		$24.8M Buy
67,000
+37,400
+126% +$12.5M 0.01% 930
2021
Q1 		$8.58M Buy
29,600
+28,100
+1,873% +$7.81M ﹤0.01% 1707
2020
Q4 		$375K Sell
1,500
-12,700
-89% -$3.02M ﹤0.01% 6116
2020
Q3 		$3.22M Sell
14,200
-60,700
-81% -$12.6M ﹤0.01% 2353
2020
Q2 		$13.1M Buy
+74,900
New +$12M 0.01% 1006

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Jane Street's CRL Position: Q2 2026 in Review

Jane Street increased its Charles River Laboratories (CRL) stake by 109% in Q2 2026, buying an estimated $395K and bringing the position to 4,251 shares worth $964K. The position accounts for ﹤0.01% of the portfolio, ranked #6628.

Jane Street first reported a position in CRL in Q2 2013 and has held it in 40 quarters since. The position peaked at $20.7M in Q1 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Jane Street held 4,251 shares of Charles River Laboratories worth $964K as of Q2 2026.
  • Jane Street bought 2,217 Charles River Laboratories shares in Q2 2026, an estimated $395K.
  • Charles River Laboratories made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6628 holding.
  • Jane Street first reported a position in Charles River Laboratories in Q2 2013 and has held it in 40 quarters since.
  • Jane Street's Charles River Laboratories position peaked at $20.7M in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.